Since it was evaluated in an acute model of colitis, and the experiment took four days in total, it would be interesting to evaluate the EPO derivate at the same doses but now in a chronic animal model of IBD, which is the objective of this experiment. Here, EPO is linked to inflammatory bowel disease.